Dataciencia

Colección SciELO Chile

Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial

Indexado

WoS	WOS:000612619500013
Scopus	SCOPUS_ID:85096938808

DOI

10.1097/HJH.0000000000002640

Año

2021

Tipo

artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Abstract

Conclusion: Intensive BP lowering is associated with increased mortality in patients with severe AIS despite lowering the risk of ICH. Further randomized trials are required to provide reliable evidence over the optimum SBP target in the most serious type of AIS.

Revista

Revista	ISSN
Journal Of Hypertension	0263-6352

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Peripheral Vascular Disease
Peripheral Vascular Diseases

Scopus
Physiology
Cardiology And Cardiovascular Medicine
Internal Medicine

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Minhas, Jatinder S.	Hombre	Univ Leicester - Reino Unido College of Life Sciences - Reino Unido
2	Wang, X.	Hombre	Univ New South Wales - Australia UNSW Medicine - Australia The University of Sydney - Australia
3	Lindley, R. I.	Hombre	Univ New South Wales - Australia UNIV SYDNEY - Australia UNSW Medicine - Australia The University of Sydney - Australia
4	Delcourt, Candice	Mujer	Univ New South Wales - Australia UNSW Medicine - Australia The University of Sydney - Australia
5	Song, LiMing	Mujer	Univ New South Wales - Australia UNSW Medicine - Australia The University of Sydney - Australia
6	Woodward, Mark	Hombre	Univ New South Wales - Australia UNIV OXFORD - Reino Unido Johns Hopkins Univ - Estados Unidos UNSW Medicine - Australia University of Oxford - Reino Unido Johns Hopkins University - Estados Unidos The University of Sydney - Australia
7	Lee, Tsong Hai	Hombre	Linkou Chang Gung Mem Hosp - Taiwán UNIV CINCINNATI - Estados Unidos Univ Leicester - Reino Unido Chang Gung Memorial Hospital - Taiwán University of Cincinnati - Estados Unidos
8	Lee, Tsong Hai	Hombre	Linkou Chang Gung Mem Hosp - Taiwán UNIV CINCINNATI - Estados Unidos Univ Leicester - Reino Unido Chang Gung Memorial Hospital - Taiwán University of Cincinnati - Estados Unidos
9	Pontes-Neto, Octavio M.	-	UNIV SAO PAULO - Brasil
10	Kim, Jong S.	-	Univ Ulsan - Corea del Sur University of Ulsan - Corea del Sur
11	Ricci, Stefano	Hombre	UO Neurol - Italia Sedi di Citta di Castello e Branca - Italia
12	Lavados, Pablo M.	Hombre	Universidad del Desarrollo - Chile
13	Bath, Philip M.	Hombre	Univ Nottingham - Reino Unido Nottingham Univ Hosp NHS Trust - Reino Unido University of Nottingham - Reino Unido Nottingham University Hospitals NHS Trust - Reino Unido
14	Lee, Tsong Hai	Hombre	Linkou Chang Gung Mem Hosp - Taiwán UNIV CINCINNATI - Estados Unidos Univ Leicester - Reino Unido Chang Gung Memorial Hospital - Taiwán University of Cincinnati - Estados Unidos
15	Wang, Ji-Guang	-	Shanghai Jiao Tong Univ - China Shanghai Jiao Tong University School of Medicine - China
16	Sharma, Vijay K.	Hombre	Natl Univ Singapore - Singapur Yong Loo Lin School of Medicine - Singapur NUS Yong Loo Lin School of Medicine - Singapur
17	Demchuk, Andrew M.	Hombre	Univ Calgary - Canadá Hotchkiss Brain Institute - Canadá
18	Martins, Sheila Cristina Ouriques	Mujer	Univ Fed Rio Grande do Sul - Brasil Hosp Moinhos de Vento - Portugal Hospital de Clínicas de Porto Alegre - Brasil Hosp Moinhos de Vento - Brasil
19	Chalmers, John	Hombre	Univ New South Wales - Australia UNSW Medicine - Australia The University of Sydney - Australia
20	Anderson, Craig	Hombre	Univ New South Wales - Australia Peking Univ - China Royal Prince Alfred Hosp - Australia UNSW Medicine - Australia Peking University Health Science Center - China Royal Prince Alfred Hospital - Australia The University of Sydney - Australia
21	Robinson, Thompson G.	-	Univ Leicester - Reino Unido College of Life Sciences - Reino Unido
22	ENCHANTED Investigators	Corporación

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento

Fuente
Department of Health
National Health and Medical Research Council
Bayer
Takeda Pharmaceutical Company
Mount Sylvia Diatomite

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
C.S.A. and L.S. report receiving grants (paid to their institution) and speaker fees and travel reimbursement from Takeda China. J.C. reports research grants from Servier and from NHMRC, paid to his institution. M.W. is a consultant to Amgen and Kirin. O.M.P.N. received speaker fees from Boehringer-Ingelheim, Pfizer, Med-tronic, Penumbra and Bayer. P.M.B. reports honoraria for Advisory Boards from DiaMedica, Moleac, Nestle, Phagenesis, and Sanofi. J.G.W. reports having received grants from Bayer and MSD and lecture and consulting fees from Novartis, Servier, and Takeda. A.M.D. is a shareholder has a granted patent with Circle NVI for stroke imaging software. S.O.M. received speaker fees from Boehringer-Ingelheim, Pfizer, Medtronic, Penumbra.

Agradecimiento

C.S.A. and L.S. report receiving grants (paid to their institution) and speaker fees and travel reimbursement from Takeda China. J.C. reports research grants from Servier and from NHMRC, paid to his institution. M.W. is a consultant to Amgen and Kirin. O.M.P.N. received speaker fees from Boehringer-Ingelheim, Pfizer, Med-tronic, Penumbra and Bayer. P.M.B. reports honoraria for Advisory Boards from DiaMedica, Moleac, Nestle, Phagenesis, and Sanofi. J.G.W. reports having received grants from Bayer and MSD and lecture and consulting fees from Novartis, Servier, and Takeda. A.M.D. is a shareholder has a granted patent with Circle NVI for stroke imaging software. S.O.M. received speaker fees from Boehringer-Ingelheim, Pfizer, Medtronic, Penumbra.